Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.

Brunoni AR, Lopes M, Fregni F.

Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80. doi: 10.1017/S1461145708009309. Epub 2008 Aug 28. Review.

PMID:
18752720
2.

BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: a systematic review and meta-analysis.

Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA.

World J Biol Psychiatry. 2015 Feb;16(2):114-22. doi: 10.3109/15622975.2014.958101. Epub 2014 Sep 29. Review.

PMID:
25264290
3.

BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis.

Brunoni AR, Baeken C, Machado-Vieira R, Gattaz WF, Vanderhasselt MA.

World J Biol Psychiatry. 2014 Jul;15(5):411-8. doi: 10.3109/15622975.2014.892633. Epub 2014 Mar 16. Review.

PMID:
24628093
4.

Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression.

Serra-Millàs M, López-Vílchez I, Navarro V, Galán AM, Escolar G, Penadés R, Catalán R, Fañanás L, Arias B, Gastó C.

Psychopharmacology (Berl). 2011 Jul;216(1):1-8. doi: 10.1007/s00213-011-2180-0. Epub 2011 Feb 11.

PMID:
21308467
5.

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.

Sen S, Duman R, Sanacora G.

Biol Psychiatry. 2008 Sep 15;64(6):527-32. doi: 10.1016/j.biopsych.2008.05.005. Epub 2008 Jun 24.

6.

MeCP2 controls hippocampal brain-derived neurotrophic factor expression via homeostatic interactions with microRNA‑132 in rats with depression.

Su M, Hong J, Zhao Y, Liu S, Xue X.

Mol Med Rep. 2015 Oct;12(4):5399-406. doi: 10.3892/mmr.2015.4104. Epub 2015 Jul 20.

PMID:
26239616
7.

Measurement methods of BDNF levels in major depression: a qualitative systematic review of clinical trials.

Teche SP, Nuernberg GL, Sordi AO, de Souza LH, Remy L, Ceresér KM, Rocha NS.

Psychiatr Q. 2013 Dec;84(4):485-97. doi: 10.1007/s11126-013-9261-7. Review.

PMID:
23564563
8.

Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.

Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, Goka E.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1256-60. Epub 2006 May 2.

PMID:
16647794
9.

Comparison of efficacy, safety and brain derived neurotrophic factor (BDNF) levels in patients of major depressive disorder, treated with fluoxetine and desvenlafaxine.

Ghosh R, Gupta R, Bhatia MS, Tripathi AK, Gupta LK.

Asian J Psychiatr. 2015 Dec;18:37-41. doi: 10.1016/j.ajp.2015.10.006. Epub 2015 Oct 19.

PMID:
26514447
10.

Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.

Huang TL, Lee CT, Liu YL.

J Psychiatr Res. 2008 Jun;42(7):521-5. Epub 2007 Jun 21.

PMID:
17585940
11.

The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.

Aydemir O, Deveci A, Taneli F.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):261-5. Epub 2004 Dec 23.

PMID:
15694233
12.

Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report.

Martocchia A, Curto M, Scaccianoce S, Comite F, Xenos D, Nasca C, Falaschi GM, Ferracuti S, Girardi P, Nicoletti F, Falaschi P.

Aging Clin Exp Res. 2014 Aug;26(4):461-4. doi: 10.1007/s40520-014-0194-2. Epub 2014 Jan 17.

PMID:
24435333
13.

Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment.

Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J, Voshaar RC, Elzinga BM.

Mol Psychiatry. 2011 Nov;16(11):1088-95. doi: 10.1038/mp.2010.98. Epub 2010 Sep 21.

14.

Neuroplasticity and memory formation in major depressive disorder: an imaging genetics perspective on serotonin and BDNF.

Kuhn M, Popovic A, Pezawas L.

Restor Neurol Neurosci. 2014;32(1):25-49. doi: 10.3233/RNN-139005. Review.

PMID:
23603442
15.

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.

Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vásquez A, Buitelaar JK, Franke B.

Mol Psychiatry. 2010 Mar;15(3):260-71. doi: 10.1038/mp.2008.109. Epub 2008 Oct 14.

PMID:
18852698
16.

Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine.

Munno D, Sterpone S, Fania S, Cappellin F, Mengozzi G, Saroldi M, Bechon E, Zullo G.

Panminerva Med. 2013 Dec;55(4):377-84.

PMID:
24434345
17.

BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.

Polyakova M, Stuke K, Schuemberg K, Mueller K, Schoenknecht P, Schroeter ML.

J Affect Disord. 2015 Mar 15;174:432-40. doi: 10.1016/j.jad.2014.11.044. Epub 2014 Nov 29. Review.

PMID:
25553404
18.
19.

Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.

Ristevska-Dimitrovska G, Shishkov R, Gerazova VP, Vujovik V, Stefanovski B, Novotni A, Marinov P, Filov I.

Psychiatr Danub. 2013 Jun;25(2):123-7.

20.

Anticipated brain molecular aging in major depression.

Douillard-Guilloux G, Guilloux JP, Lewis DA, Sibille E.

Am J Geriatr Psychiatry. 2013 May;21(5):450-60. doi: 10.1016/j.jagp.2013.01.040. Epub 2013 Feb 6.

Supplemental Content

Support Center